Bora Decebal

Biography

Decebal Bora is an experienced regulatory affairs professional with more than 20 years of experience in the field. As VP Regulatory Affairs at Promethera, Decebal leads all regulatory affairs activities on a strategic and operational level as well as serves on the executive management team. Prior to joining Promethera, Decebal was Executive Director Regulatory Affairs at PTC Therapeutics, where he established and developed PTC’s footprint in regions of Europe, the Middle East and Africa. Decebal has also worked for several internationally operating biopharmaceutical companies such as Biogen Inc., F. Hoffmann-La Roche Ltd, Baxter World trade and ActoGeniX N.V, where he served as Director Regulatory Affairs and was responsible for all interaction with the FDA, EMA and national agencies involved with GMO/Gene Therapy. He also strategized and implemented the development of new products. Dr. Bora holds a Pharm.D. degree from the Catholic University of Louvain (Belgium) and a master's degree in public health from Jean Monnet Faculty in Sceaux, France. He has also been appointed BTEC fellow by the North Carolina State University College of Engineering for his contributions to the Biomanufacturing Training and Education Center (BTEC). Decebal Bora is an experienced regulatory affairs professional with more than 20 years of experience in the field. As VP Regulatory Affairs at Promethera, Decebal leads all regulatory affairs activities on a strategic and operational level as well as serves on the executive management team. Prior to joining Promethera, Decebal was Executive Director Regulatory Affairs at PTC Therapeutics, where he established and developed PTC’s footprint in regions of Europe, the Middle East and Africa. Decebal has also worked for several internationally operating biopharmaceutical companies such as Biogen Inc., F. Hoffmann-La Roche Ltd, Baxter World trade and ActoGeniX N.V, where he served as Director Regulatory Affairs and was responsible for all interaction with the FDA, EMA and national agencies involved with GMO/Gene Therapy. He also strategized and implemented the development of new products. Dr. Bora holds a Pharm.D. degree from the Catholic University of Louvain (Belgium) and a master's degree in public health from Jean Monnet Faculty in Sceaux, France. He has also been appointed BTEC fellow by the North Carolina State University College of Engineering for his contributions to the Biomanufacturing Training and Education Center (BTEC).

Research Interest

Pharmaceutical Science